secwatch.observer — SEC 8-K summary
======================================

Issuer:     bioAffinity Technologies, Inc. (BIAF)
CIK:        0001712762
Form:       8-K
Filed at:   2023-12-05T23:59:59+00:00
Accession:  0001493152-23-043665
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

bioAffinity appoints Jamie Platt to board; Mohsin Meghji resigns
----------------------------------------------------------------

- Jamie Platt, Ph.D., appointed to board effective Dec. 1, 2023; also joins Compensation Committee.
- Platt brings 20 years of genomics/diagnostics experience; led two M&A exits worth ~$1B combined.
- Mohsin Meghji resigned same day for personal reasons, no disagreement with company.
- Platt receives standard non-employee director compensation: $25k annual fee + quarterly restricted stock grant valued at $18,750.
- She currently serves as CEO of Pictor Ltd. and President/CEO of BRIDGenomics.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1712762/000149315223043665/0001493152-23-043665-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1712762/000149315223043665/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-043665

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer